Meet Rekha Rakesh Jhunjhunwala, the top Indian entrant in 2023 M3M Hurun Global Rich List

Mar 22, 2023

By: Rounak Jain

Credit: BCCL

Meet Rekha Rakesh Jhunjhunwala

Rekha Rakesh Jhunjhunwala has emerged as the top Indian entrant in the 2023 M3M Hurun Global Rich List. She is the widow of Indian stock market mogul Rakesh Jhunjhunwala who passed away last year.

Credit: BCCL

Here’s how much her stock portfolio is worth

According to data from Trendlyne, Rekha Jhunjhunwala’s stock portfolio is currently worth ₹25,656 crore, with investments in 29 companies.

Credit: BCCL

Inherited late husband’s stock portfolio

In addition to her own stock investments, Rekha Jhunjhunwala also inherited the stock portfolio of her late husband Rakesh Jhunjhunwala, who was known as the Big Bull.

Credit: BCCL

Value of late husband’s stock portfolio

Rekha Jhunjhunwala also looks after her late husband’s stock portfolio which has investments worth ₹32,108 crore across 29 companies.

Credit: BCCL

Rekha Jhunjhunwala’s top stock holdings

Titan, Tata Motors, Metro Brands, Crisil and Canara Bank are Rekha Jhunjhunwala’s top five stock holdings.

Credit: BCCL

Titan alone accounts for nearly 40 percent of their investments

At ₹23,023 crore, Titan Company alone accounts for nearly 40 percent of the total investments of the Jhunjhunwalas.

Credit: BCCL

Net worth of $5.9 billion

According to Forbes, Rekha Jhunjhunwala has a net worth of $5.9 billion.

Credit: BCCL

Director of four companies

According to data from the Ministry of Corporate Affairs, Rekha Jhunjhunwala is on the board of directors of Rare Family Foundation, Rare Equity, Jalaram Baba Children’s Nest Education, and Minosha Digital Solutions.

Credit: BCCL

Joining Sankara Eye Foundation India’s Board of Trustees

Rekha Jhunjhunwala also joined Sankara Eye Foundation India’s Board of Trustees as part of her philanthropy efforts. The foundation currently performs over 2 lakh free eye surgeries every year in India.

Credit: Twitter

Here are India’s top 10 richest women from pharma, tech and other sectors